Skip to main content

Table 1 Patient Population Demographics

From: Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study

Demographic

All patients

DMD-treated

Not DMD treated

 

N = 11,061

n = 4,462

n = 6,599

Gender

   

   Male

25.8%

23.7%

27.2%

   Female

74.2%

76.3%

72.8%

Age (in years, mean ± SD)

50.3 ± 13.3

44.5 ± 10.6

54.3 ± 13.4

   18-34

11.5%

18.4%

6.8%

   35-44

21.5%

30.4%

15.5%

   45-54

31.2%

33.5%

29.7%

   55-64

22.5%

15.6%

27.2%

   65+

13.2%

2.2%

20.7%

Insurance Type

   

   Commercial

85.1%

96.9%

77.1%

   Medicare

14.9%

3.1%

22.9%

Geographic Region

   

   Northeast

12.9%

12.8%

13.0%

   North Central

35.6%

32.0%

38.0%

   South

30.4%

35.5%

27.0%

   West

20.5%

19.2%

21.3%

   Unknown

0.6%

0.5%

0.7%

Index year

   

   2001

7.5%

8.0%

7.2%

   2002

12.9%

13.0%

12.9%

   2003

16.8%

17.7%

16.1%

   2004

24.0%

22.1%

25.4%

   2005

22.2%

22.5%

21.9%

   2006*

16.6%

16.7%

16.5%

Length of follow-up (in months, mean ± SD)

35.7 ± 17.5

36.7 ± 17.6

35.1 ± 17.5

  1. *Patients who indexed on January 1, 2007 are included in 2006 category